HUSSMAN STRATEGIC ADVISORS, INC. — 13F Holdings & Portfolio
CIK 1179475 · latest 13F-HR filed 2026-08-03
HUSSMAN STRATEGIC ADVISORS, INC. manages $434.0M in 13F-reported U.S. long-equity assets across 231 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are PEP (1.18%), UI (1.16%), INCY (1.10%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 66 new positions and exited 103; 71 existing positions rose in reported value and 59 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-08-03
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
Portfolio map
Q2 26Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.
Sector mix
% of 13F valueSectors from each company's SIC code; funds and ETFs grouped separately.
Biggest buys and sells
Q1 26 → Q2 26Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.
13F assets and positions
4 quartersTotal reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.
Top positions over time
reported valueThe eight largest current positions, valued at each quarter end.
Concentration
top 10 = 10.4%Cumulative share of the portfolio held in the largest N positions.
As of the firm’s regulatory filing dated Jan 22, 2026.
SUITE 490
ELLICOTT CITY, MD 21043
| Name | Title / Status | Ownership | Type |
|---|---|---|---|
| HUSSMAN, JOHN, PETER Control | PRESIDENT since Aug 1999 | 75% or more | Individual |
| STEINAU, BROOKE, SUZANNE Control | CHIEF COMPLIANCE OFFICER since Apr 2022 | Less than 5% | Individual |
Ownership & leadership changes · 2 filings with changes since Mar 9, 2012
From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.
- No longer listedPatton, Kevin, Jason · CHIEF COMPLIANCE OFFICER · Less than 5% · control person · listed since Feb 2022
- AddedSTEINAU, BROOKE, SUZANNE · CHIEF COMPLIANCE OFFICER · Less than 5% · control person
- No longer listedSPLAIN, JOHN, FISCHER · CHIEF COMPLIANCE OFFICER · Less than 5% · listed since Oct 2004
- AddedPatton, Kevin, Jason · CHIEF COMPLIANCE OFFICER · Less than 5% · control person
- ListedHUSSMAN, JOHN, PETER · PRESIDENT · 75% or more · control person
- ListedSPLAIN, JOHN, FISCHER · CHIEF COMPLIANCE OFFICER · Less than 5%
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- PEPSICO INC$3.5M +213.9%
- BIOGEN INC$3.4M +292.8%
- CIMPRESS PLC$2.7M +178.6%
- HERSHEY CO$2.7M +153.2%
- AURINIA PHARMACEUTICALS INC$2.3M +186.3%
Top Trims
- CONCENTRIX CORP-$3.1M -76.6%
- ACADIA PHARMACEUTICALS INC-$2.1M -57.4%
- MAXIMUS INC-$1.6M -58.1%
- ANI PHARMACEUTICALS INC-$1.4M -35.4%
- SYSCO CORP-$1.4M -60.9%
New Positions
- TERADATA CORP DEL$3.6M
- PACS GROUP INC$3.6M
- PROVIDENT FINL SVCS INC$3.5M
- GLOBUS MED INC$3.3M
- SALESFORCE INC$3.3M
Exited Positions
- CORCEPT THERAPEUTICS INC$5.1M
- SEZZLE INC$4.0M
- POWER SOLUTIONS INTL INC$3.8M
- QUALYS INC$3.7M
- PROGYNY INC$3.6M
HUSSMAN STRATEGIC ADVISORS, INC. Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | PEPSICO INC | PEP | 713448108 | $5.1M | 1.18% | 37,800 | SH |
| 2 | UBIQUITI INC | UI | 90353W103 | $5.0M | 1.16% | 9,450 | SH |
| 3 | INCYTE CORP | INCY | 45337C102 | $4.8M | 1.10% | 42,000 | SH |
| 4 | VIASAT INC | VSAT | 92552V100 | $4.7M | 1.09% | 52,500 | SH |
| 5 | NEUROCRINE BIOSCIENCES INC | NBIX | 64125C109 | $4.6M | 1.06% | 27,300 | SH |
| 6 | BIOGEN INC | BIIB | 09062X103 | $4.5M | 1.05% | 21,000 | SH |
| 7 | HERSHEY CO | HSY | 427866108 | $4.4M | 1.02% | 25,200 | SH |
| 8 | CIMPRESS PLC | CMPR | G2143T103 | $4.3M | 0.98% | 42,000 | SH |
| 9 | ZIFF DAVIS INC | ZD | 48123V102 | $3.8M | 0.89% | 73,500 | SH |
| 10 | UNITED NAT FOODS INC | UNFI | 911163103 | $3.8M | 0.88% | 84,000 | SH |
| 11 | ULTA BEAUTY INC | ULTA | 90384S303 | $3.8M | 0.87% | 8,400 | SH |
| 12 | THE CAMPBELLS COMPANY | CPB | 134429109 | $3.7M | 0.86% | 168,000 | SH |
| 13 | GENERAL MILLS INC | GIS | 370334104 | $3.7M | 0.84% | 105,000 | SH |
| 14 | TERADATA CORP DEL | TDC | 88076W103 | $3.6M | 0.84% | 105,000 | SH |
| 15 | DOLLAR GEN CORP | DG | 256677105 | $3.6M | 0.84% | 31,500 | SH |
| 16 | AMERICAN EAGLE OUTFITTERS IN | AEO | 02553E106 | $3.6M | 0.83% | 210,000 | SH |
| 17 | PACS GROUP INC | PACS | 69380Q107 | $3.6M | 0.83% | 84,000 | SH |
| 18 | AURINIA PHARMACEUTICALS INC | AUPH | 05156V102 | $3.6M | 0.82% | 210,000 | SH |
| 19 | MADDEN STEVEN LTD | SHOO | 556269108 | $3.5M | 0.81% | 84,000 | SH |
| 20 | PROVIDENT FINL SVCS INC | PFS | 74386T105 | $3.5M | 0.80% | 147,000 | SH |
| 21 | PROTO LABS INC | PRLB | 743713109 | $3.4M | 0.79% | 42,000 | SH |
| 22 | APA CORPORATION | APA | 03743Q108 | $3.4M | 0.79% | 105,000 | SH |
| 23 | NEWMONT CORP | NEM | 651639106 | $3.4M | 0.79% | 36,600 | SH |
| 24 | BARRICK MNG CORP | B | 06849F108 | $3.4M | 0.77% | 91,500 | SH |
| 25 | MERCURY GENL CORP NEW | MCY | 589400100 | $3.4M | 0.77% | 31,500 | SH |
| 26 | MEDPACE HLDGS INC | MEDP | 58506Q109 | $3.3M | 0.77% | 6,300 | SH |
| 27 | TOOTSIE ROLL INDS INC | TR | 890516107 | $3.3M | 0.77% | 84,000 | SH |
| 28 | GLOBUS MED INC | GMED | 379577208 | $3.3M | 0.76% | 42,000 | SH |
| 29 | SALESFORCE INC | CRM | 79466L302 | $3.3M | 0.76% | 21,000 | SH |
| 30 | HALOZYME THERAPEUTICS INC | HALO | 40637H109 | $3.3M | 0.76% | 42,000 | SH |
| 31 | BANK OZK LITTLE ROCK ARK | OZK | 06417N103 | $3.3M | 0.76% | 63,000 | SH |
| 32 | REGENERON PHARMACEUTICALS | REGN | 75886F107 | $3.3M | 0.75% | 5,250 | SH |
| 33 | MATCH GROUP INC NEW | MTCH | 57667L107 | $3.2M | 0.74% | 84,000 | SH |
| 34 | ETSY INC | ETSY | 29786A106 | $3.2M | 0.73% | 42,000 | SH |
| 35 | VISTEON CORP | VC | 92839U206 | $3.1M | 0.72% | 31,500 | SH |
| 36 | YETI HLDGS INC | YETI | 98585X104 | $3.1M | 0.72% | 63,000 | SH |
| 37 | HEALTHCARE SVCS GROUP INC | HCSG | 421906108 | $3.1M | 0.71% | 126,000 | SH |
| 38 | AMGEN INC | AMGN | 031162100 | $3.0M | 0.70% | 8,400 | SH |
| 39 | NEXTPOWER INC | NXT | 65290E101 | $3.0M | 0.69% | 25,200 | SH |
| 40 | ALPHABET INC | GOOGL | 02079K305 | $3.0M | 0.69% | 8,400 | SH |
| 41 | T1 ENERGY INC | TE | 35834F104 | $3.0M | 0.69% | 315,000 | SH |
| 42 | INHIBRX BIOSCIENCES INC | INBX | 45720N103 | $3.0M | 0.69% | 31,500 | SH |
| 43 | AKAMAI TECHNOLOGIES INC | AKAM | 00971T101 | $3.0M | 0.69% | 25,200 | SH |
| 44 | URBAN OUTFITTERS INC | URBN | 917047102 | $3.0M | 0.69% | 42,000 | SH |
| 45 | MACYS INC | M | 55616P104 | $3.0M | 0.68% | 126,000 | SH |
| 46 | BREAD FINANCIAL HOLDINGS INC | BFH | 018581108 | $3.0M | 0.68% | 27,300 | SH |
| 47 | AMERESCO INC | AMRC | 02361E108 | $2.9M | 0.67% | 105,000 | SH |
| 48 | TG THERAPEUTICS INC | TGTX | 88322Q108 | $2.9M | 0.66% | 52,500 | SH |
| 49 | AGNICO EAGLE MINES LTD | AEM | 008474108 | $2.8M | 0.65% | 18,300 | SH |
| 50 | LEAR CORP | LEA | 521865204 | $2.8M | 0.65% | 21,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-03 | $434.0M | 231 | 0001398344-26-013356 |
| 2026-03-31 | 2026-05-11 | $462.5M | 268 | 0001398344-26-008833 |
| 2025-12-31 | 2026-02-02 | $413.7M | 252 | 0001398344-26-001810 |
| 2025-09-30 | 2025-11-03 | $461.8M | 270 | 0001398344-25-020162 |
ELLICOTT CITY, MD 21043